Early and consistent improvements in urinary symptoms and quality of life with onabotulinumtoxinA in overactive bladder patients with urinary incontinence in a multicenter, randomized, placebo-controlled, phase 4 trial
- Resource Type
- Abstract
- Source
- In
Toxicon December 2018 156 Supplement 1:S79-S79 - Subject
- Language
- ISSN
- 0041-0101